|
|
Health officials are expressing concerns about the upcoming respiratory
virus season and are urging eligible individuals to receive vaccines
against Covid, flu, and RSV.
The season is expected to present challenges
due to the potential co-circulation of these viruses,
and experts emphasize
the importance of getting vaccinated to prepare for what could be an
intense winter respiratory season.
The overlap of vaccination campaigns
against COVID-19, the flu, and RSV will be a significant challenge, but
health officials emphasize the importance of getting vaccinated
regardless of timing uncertainties to mitigate the risk of severe respiratory
illnesses.
|
The U.S. experienced an all-time high in suicides in 2022, with
approximately 49,500 individuals taking their own lives, marking a 3%
increase from 2021, according to provisional data from U.S. death
certificates.
Experts attribute this rise to various factors, including higher
rates of depression and limited access to mental health services. The
increasing availability of guns is considered a key driver, as suicide
attempts involving firearms are more likely to result in death.
Despite
efforts to address the issue, suicides remain a complex challenge with
multifaceted causes.
|
The obesity drug Wegovy, produced by Novo Nordisk, has been found to
reduce the risk of cardiovascular events like heart attacks and strokes
by 20%, according to preliminary findings from a late-stage clinical trial
involving over 17,000 adults with overweight or obesity and existing
cardiovascular disease.
This marks the first time a weight-loss drug has
demonstrated medical benefits beyond weight reduction.
The results
could potentially change the perception of Wegovy from a cosmetic or
vanity drug to one with significant health benefits, potentially leading to
increased insurance coverage for its use. The drug has been linked to
potential cardiovascular benefits, but further research is needed to
understand the mechanism behind these effects.
|
|
|